nav-left cat-right

Canagliflozin Amputee Attorney

The FDA warning suggests physicians should consider factors that predispose patients to amputations, such as prior amputations, peripheral vascular disease, Canagliflozin amputee attorney neuropathy and diabetic foot ulcers, before prescribing the drug.All fields required.Decreased Kidney Function.The lawsuits are combined before a federal judge in New Jersey where all discovery and evidence gathering is taking place.If you have suffered serious kidney or blood infections, or if you suffered kidney failure while taking Invokana, call us today.For a limited time, our Invokana® lawsuit lawyers are offering FREE legal consultations to those who have suffered an amputation while taking the drug.Canagliflozin also has been linked to decreases in bone mineral density in the hip and spine.

DKA is caused by increased levels of acids in the blood, known as ketones.So far, the FDA has only issued the label warning for canafliglozin, not for other drugs."Even though amputation was a significant event for patients … both physically and psychologically, 10 of the 15 suffered toe or metatarsal (across the foot) amputations and only five had above the ankle amputations," he said.All fields required." They added that there were questions even at the time of FDA approval, when the administration expressed the concern that the long-term consequences of taking the drug were unknown, and that it was "prudent to assume" that the slight reduced kidney function seen in the studies "places patients at increased risk for clinically significant episodes of acute kidney injury.

" Reported in FDA Invokana Safety – Kidney Issues.The second clinical trial found a higher rate of amputation among patients being treated with Invokana over a 12-month period.Simply fill out the form below and one of our lawyers will promptly call you for your free legal consultation!Serious Urinary Tract Infections—Taking Invokana or other SGLT2 Inhibitors increases the risk of developing serious urinary tract infections which can cause inflammation of the kidneys and damage to kidney function.A May 2017 FDA Drug Safety Communication stated, "Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations.Call me, Conal Doyle, Amputation Attorney, at 310-651-8272.

If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.Instead, they asked Janssen to conduct 5 post-marketing studies to determine if Invokana increases these risks, according to the New York Times.The kidneys naturally remove sugar from the blood, but the sugar is then.I can help.The condition requires immediate medical attention and in some cases, hospitalization.

The results again showed that patients treated with Invokana had a two-times-greater risk for amputations than patients treated with a placebo.

Comments are closed.